U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938177) titled 'Clinical High Risk for Psychosis (CHR) Cohort' on Nov. 10.

Brief Summary: This study aims to establish a standardized, prospective longitudinal cohort of individuals at clinical high risk for psychosis (CHR) to improve early identification, risk prediction, and outcome assessment of psychotic disorders.

The study will recruit individuals at CHR and healthy controls at Shanghai Mental Health Center. Participants will undergo comprehensive assessments covering clinical symptoms, neurocognitive functioning, psychosocial functioning, and multimodal biological characteristics. Assessments will include standardized clinical interviews an...